| Tag | Content |
|---|
EnhancerAtlas ID | HS023-09249 |
Organism | Homo sapiens |
Tissue/cell | CD8+ |
Coordinate | chr16:28934970-28935720 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| STAT3 | MA0144.2 | chr16:28935374-28935385 | TTTCCCAGAAG | - | 6.62 | | Stat4 | MA0518.1 | chr16:28935371-28935385 | CTATTTCCCAGAAG | - | 6.16 | | Tcf12 | MA0521.1 | chr16:28934982-28934993 | CAGCAGCTGTT | - | 6.32 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10806 | chr16:28934105-28937640 | CD19_Primary | | SE_11724 | chr16:28932064-28938989 | CD20 | | SE_54362 | chr16:28934039-28937660 | Spleen | | SE_62078 | chr16:28933981-28957654 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | GTCTCCAGCC ACCAGCAGCT GTTAGAAAGG GAAATCGCAT GTTGGGAAGG GAATTTTAGG 60
AAGTTTACTC TGGAAGCCAA TGTCAAGGCC ACACTATAGA GGAAGATCTG TGAGAAGGTT 120
GGGACAAAAG TCCAGGAGAG AGTTGACGAG AGCCCCACCG CAGCAGGGGC ATAGCAGCGG 180
GGGCAGCTCT GACATCTGTT TCAGAGTCTC TGGCTTCTGC TAGAGGAAGG AGAGTAGAAA 240
ACAGGATCAG CAGCTGGGGC GTCTGGGGCC AGAGGACCAA GTACAAAGAA CGTGGGGCGG 300
AGGTGGGGAA GCTGGTGCAT GGCGTGGGGT GGAGGGGGGA GTGTCTGGGG AAGGCTAGAG 360
AGCAGAGCAT TAGACTCACA GAGACTGGGC CAGGGCTGAT TCTATTTCCC AGAAGTCCAG 420
ACTAAAATGA GGTTGGTTTG GGGAACTGAG AAGTTTCTCG CCCATCTTCA GGGTTGATCA 480
ATCATCAGTG AGGGACAAGA AATGACATGG GACAAGGCAA CAGATAGAAG CTGGGAGCTA 540
AACTTAGCTA TAACTGACAG AGCTGCTGCT ATCACATGGA GGGCCTCTAT GCAAATTTTA 600
AAAGGGCGGC CCTTCCTCTG GGCCATAGGC ATGCCCTGTG CCAGGCAGCC CTGCTAACCT 660
ATCCCATAGC TTATCTGTGC CCCCAATCCC TTTCTCGTCA TGCACTCCCC AGTATGGGGT 720
TGATGGGGAG TCTAGGTGAG TCCCGCGTCT 750
|
